445 related articles for article (PubMed ID: 17301720)
1. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
4. Optic radiation involvement in optic pathway gliomas in neurofibromatosis.
Liu GT; Brodsky MC; Phillips PC; Belasco J; Janss A; Golden JC; Bilaniuk LL; Burson GT; Duhaime AC; Sutton LN
Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861
[TBL] [Abstract][Full Text] [Related]
5. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
6. Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1.
Sylvester CL; Drohan LA; Sergott RC
Curr Opin Ophthalmol; 2006 Feb; 17(1):7-11. PubMed ID: 16436918
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; García-Segura JM; Botella MP
Rev Neurol; 2008 May 1-15; 46(9):530-6. PubMed ID: 18446694
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
[TBL] [Abstract][Full Text] [Related]
9. [Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach].
Zuccoli G; Ferrozzi F; Signorini M; Virdis R; Troiso A
Radiol Med; 2001 May; 101(5):382-5. PubMed ID: 11438792
[TBL] [Abstract][Full Text] [Related]
10. Optic-pathway glioma: natural history demonstrated by a new empirical score.
Schupper A; Kornreich L; Yaniv I; Cohen IJ; Shuper A
Pediatr Neurol; 2009 Jun; 40(6):432-6. PubMed ID: 19433276
[TBL] [Abstract][Full Text] [Related]
11. Intracranial visual pathway gliomas in children with neurofibromatosis.
Packer RJ; Bilaniuk LT; Cohen BH; Braffman BH; Obringer AC; Zimmerman RA; Siegel KR; Sutton LN; Savino PJ; Zackai EH
Neurofibromatosis; 1988; 1(4):212-22. PubMed ID: 3152473
[TBL] [Abstract][Full Text] [Related]
12. Natural history and outcome of optic pathway gliomas in children.
Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
[TBL] [Abstract][Full Text] [Related]
13. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
15. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
[TBL] [Abstract][Full Text] [Related]
16. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
17. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
18. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
Sharif S; Ferner R; Birch JM; Gillespie JE; Gattamaneni HR; Baser ME; Evans DG
J Clin Oncol; 2006 Jun; 24(16):2570-5. PubMed ID: 16735710
[TBL] [Abstract][Full Text] [Related]
19. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
20. Visual loss in orbitofacial neurofibromatosis type 1.
Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]